Add to ORKGThe goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position emission tomography (PET) imaging and radiotherapy of cancer. Copper-64 radiopharmaceuticals have been used as PET imaging agents for various diseases because of the favorable decay characteristics of 64Cu (t1/2 = 12.7 h; β+ (17.8%); β- (38.4%))
Although the concept of theranostics is neither new nor exclusive to nuclear medicine, it is a parti...
Recently, the somatostatin receptor subtype 2 (SSTR2) selective antagonist sst2-ANT was determined t...
PET imaging has gained significant momentum in the last few years, especially in the area of oncolog...
The goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position...
This study investigated several somatostatin analogues labeled with copper-64 for imaging and target...
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in oncology,...
The goal of this dissertation is to evaluate the feasibility of applying 64Cu radiopharmaceuticals i...
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide (64C...
Imaging of somatostatin receptor expression is an established technique for staging of neuroendocrin...
The advancement of positron emission tomography (PET) depends on the development of new radiotracers...
Bianca Gutfilen,1 Sergio AL Souza,1 Gianluca Valentini2 1Department of Radiology, School of Medicin...
A bifunctional chelator for stably complexing metal radionuclides to tumor-targeting molecules is cr...
The contribution of positron emission tomography (PET) to the drug discovery and development (D3) pi...
At present, various copper radioisotopes are produced by cyclotrons for targeted imaging and treatme...
In this proposal has been developed a prototype of radiopharmaceutical based on the radioactive iso...
Although the concept of theranostics is neither new nor exclusive to nuclear medicine, it is a parti...
Recently, the somatostatin receptor subtype 2 (SSTR2) selective antagonist sst2-ANT was determined t...
PET imaging has gained significant momentum in the last few years, especially in the area of oncolog...
The goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position...
This study investigated several somatostatin analogues labeled with copper-64 for imaging and target...
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in oncology,...
The goal of this dissertation is to evaluate the feasibility of applying 64Cu radiopharmaceuticals i...
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide (64C...
Imaging of somatostatin receptor expression is an established technique for staging of neuroendocrin...
The advancement of positron emission tomography (PET) depends on the development of new radiotracers...
Bianca Gutfilen,1 Sergio AL Souza,1 Gianluca Valentini2 1Department of Radiology, School of Medicin...
A bifunctional chelator for stably complexing metal radionuclides to tumor-targeting molecules is cr...
The contribution of positron emission tomography (PET) to the drug discovery and development (D3) pi...
At present, various copper radioisotopes are produced by cyclotrons for targeted imaging and treatme...
In this proposal has been developed a prototype of radiopharmaceutical based on the radioactive iso...
Although the concept of theranostics is neither new nor exclusive to nuclear medicine, it is a parti...
Recently, the somatostatin receptor subtype 2 (SSTR2) selective antagonist sst2-ANT was determined t...
PET imaging has gained significant momentum in the last few years, especially in the area of oncolog...